Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration · Department of Health and Human Services
At a glance
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) is a forecasted federal grant opportunity from the Food and Drug Administration (Department of Health and Human Services). The agency has forecast this opportunity but has not yet set an application deadline. Individual awards are listed as up to $400K. Applicant types listed as eligible include others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- Jul 11, 2025
- Est. close date
- Not listed
- Award floor
- Not specified
- Award ceiling
- $400,000
- Est. total funding
- Not specified
- Expected awards
- Not specified
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
- Fiscal year
- FY2025
Who can apply
- Others (see notice)
Additional information on eligibility (from the notice)
Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Local Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Federal Governments U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) Foreign Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Assistance Listing
What is an ALN?Reported obligations under ALN 93.103
Historical data · not a predictionAgency contact (as published)
Kimberly Pendleton
Kimberly.Pendleton@fda.hhs.gov
240-402-7610
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: Others (see notice). Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as up to $400k.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity FOR-FD-25-017), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration- Award range
- Up to $250K
- Closes
- Jan 29, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration- Award range
- Up to $200K
- Closes
- Apr 1, 2027
- Who can apply
- Others (see notice)
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration- Award range
- Up to $600K
- Closes
- Feb 8, 2028
- Who can apply
- Others (see notice)
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration- Award range
- Up to $1.25M
- Closes
- May 12, 2028
- Who can apply
- Public colleges & universities, Private colleges & universities and Others (see notice)
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration- Award range
- Up to $900K
- Closes
- May 16, 2028
- Who can apply
- Others (see notice)
Retail Food Safety Regulatory Association Collaboration
Food and Drug Administration- Award range
- Amount not specified
- Est. close
- Not yet set
- Who can apply
- Others (see notice)